Universe Pharmaceuticals INC (UPC) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$17.9B

Net Income/Loss (FY2025)

-$3.7B

Total Assets (FY2025)

$69.3B

Total Equity (FY2025)

$56.1B

Cash Flows from Operating Activities (FY2025)

-$5.1B

Source: Universe Pharmaceuticals INC 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.